Search results
Vertex Is Writing A New Playbook For Pharma R&D. And It’s Working.
Forbes· 1 day ago...Sovaldi in December 2013 directly causing Incivek’s commercial flameout, Jeff Leiden, M.D.,...
Vertex Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 7 days agoVertex Pharmaceuticals (NASDAQ:VRTX) First Quarter 2024 Results Key Financial Results Revenue:...
5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip
Motley Fool via Yahoo Finance· 7 days agoShares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 8% from a peak they reached this...
Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Growth Stock
Zacks· 1 day agoFor new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...
A Closer Look at Vertex Pharmaceuticals's Options Market Dynamics - Vertex Pharmaceuticals...
Benzinga· 7 days agoLoading... Loading... Financial giants have made a conspicuous bullish move on Vertex Pharmaceuticals. Our analysis of options history for Vertex ...
Alpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Ami
Guru Focus· 5 days agoThis announcement comes in the wake of a significant development where Vertex Pharmaceuticals Incorporated agreed to acquire Alpine for $65 per share in ...
Vertex (VRTX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks via Yahoo Finance· 7 days agoAlthough the revenue and EPS for Vertex (VRTX) give a sense of how its business performed in the...
Catalyst Pharmaceuticals Stock Clears Technical Benchmark With 83 RS Rating
Investor's Business Daily· 13 hours agoThe biotech company reported -7% earnings growth in its most recent report, while sales growth came...
2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade | The Motley Fool
The Motley Fool· 3 days agoThe stock market has taken investors for a wild ride these last few years. When you're investing in...
Catalyst Pharmaceuticals Stock Clears Technical Benchmark With 83 RS Rating
Investor's Business Daily· 13 hours agoOver 100 years of market history reveals that the stocks that go on to make the biggest gains tend...